FDA Inspection
Genzyme CorporationGenzyme Corporation – FDA Inspection, Jul 9, 2024
Record Details
This FDA Inspection record concerns Genzyme Corporation, with an inspection on July 9, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a68d998d-31e2-47dc-b3c9-bfb31e8d55f1
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1232210
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
Other FDA inspections of Genzyme Corporation
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2026 | Not classified | New England District Office | |
| July 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Genzyme Corporation
- FDA Inspection 1294652 - 2026-04-09
- FDA Inspection 1176107 - 2022-07-25
- FDA Inspection 1003362 - 2017-02-02
- FDA Inspection 904958 - 2014-11-21
- FDA Inspection 897241 - 2014-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.